Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Top Cited Papers
- 1 July 2013
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 106-107, 17-32
Abstract
No abstract availableKeywords
This publication has 262 references indexed in Scilit:
- A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) MiceNeurotherapeutics, 2012
- Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activitiesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseasesBrain Research Reviews, 2011
- Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Redox imbalance in Parkinson's diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Mitochondrial localization of DJ‐1 leads to enhanced neuroprotectionJournal of Neuroscience Research, 2008
- Mice with Mitochondrial Complex I Deficiency Develop a Fatal EncephalomyopathyCell Metabolism, 2008
- Cell systems and the toxic mechanism(s) of α-synucleinExperimental Neurology, 2008
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003